MoneyWorks4Me

Dr. Reddys Lab reports Profit after tax of Rs 3115.00 Mln, in the March 2021 quarter

14 May 2021 Evaluate
The March 2021 quarter revenue stood at Rs. 33507.00 millions, up 17.50% as compared to Rs. 28517.00 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 3115.00 millions from Rs. 5028.00 millions, a decline of -38.05% on QoQ basis.The company reported a good operating profit of 6845.00 millions compared to 6482.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202103 202003 % Var
Sales 33507.00 28517.00 17.50 133491.00 118504.00 12.65 133491.00 118504.00 12.65
Other Income 816.00 1274.00 -35.95 8011.00 7432.00 7.79 8011.00 7432.00 7.79
PBIDT 6845.00 6482.00 5.60 39529.00 36128.00 9.41 39529.00 36128.00 9.41
Interest 169.00 118.00 43.22 467.00 478.00 -2.30 467.00 478.00 -2.30
PBDT 6676.00 6364.00 4.90 39062.00 35650.00 9.57 39062.00 35650.00 9.57
Depreciation 2107.00 1923.00 9.57 8500.00 7892.00 7.70 8500.00 7892.00 7.70
PBT 4569.00 4441.00 2.88 30562.00 27758.00 10.10 30562.00 27758.00 10.10
TAX 1454.00 -587.00 -347.70 8698.00 -1619.00 -637.25 8698.00 -1619.00 -637.25
Deferred Tax 666.00 -1277.00 -152.15 3297.00 -6458.00 -151.05 3297.00 -6458.00 -151.05
PAT 3115.00 5028.00 -38.05 21864.00 29377.00 -25.57 21864.00 29377.00 -25.57
Equity 832.00 831.00 0.12 832.00 831.00 0.12 832.00 831.00 0.12
PBIDTM(%) 20.43 22.73 -10.13 29.61 30.49 -2.87 29.61 30.49 -2.87
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..